Eosinophils are white blood cells that, when they accumulate in skin tissue, produce a distinctive set of symptoms: itching that can range from mild to almost unbearable, red or swollen patches, hives, blisters, and in some cases hardened or thickened skin. The causes behind this buildup span a wide range, from allergic conditions and drug reactions to parasitic infections and rare blood disorders. What makes eosinophilia in the skin particularly tricky is that its appearance varies so much depending on the underlying trigger, and eosinophils cause damage through mechanisms that can persist in tissue for days to weeks after the cells themselves have arrived.
What Eosinophils Actually Do to Skin
Eosinophils carry granules packed with proteins that are essentially toxic to surrounding tissue. When these cells degranulate in the skin, they release four main proteins: major basic protein (MBP), eosinophil cationic protein (ECP), eosinophil-derived neurotoxin (EDN), and eosinophil peroxidase (EPO). These proteins kill skin cells directly, ramp up local inflammation, and make blood vessels leakier, which is what produces the redness and swelling you see on the surface. Each of these granule proteins increases the permeability of skin blood vessels at a potency comparable to histamine, and they do so through both histamine-dependent and histamine-independent pathways. That dual mechanism helps explain why antihistamines alone often fail to fully control eosinophilic skin conditions: blocking histamine only addresses part of the problem.1Journal of Allergy and Clinical Immunology. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization
These proteins also do not disappear quickly. Pathophysiologically relevant concentrations of eosinophil granule proteins can alter skin function for days to weeks, meaning the damage can continue well after the initial inflammatory trigger has resolved. This is one reason eosinophilic skin diseases tend to feel chronic and slow to heal even with treatment.
Why Eosinophilic Skin Conditions Itch So Intensely
Most eosinophilic skin conditions share one miserable feature: intense itching. Conditions like atopic dermatitis, prurigo nodularis, and scabies are all associated with eosinophil-driven itch that can be severe enough to disrupt sleep and daily life. Eosinophils contribute to this by releasing granule proteins and a cocktail of mediators including substance P, nerve growth factor, and several cytokines. Among these, IL-31 has emerged as a key driver of itch in atopic dermatitis, prurigo nodularis, and bullous pemphigoid, with eosinophils directly contributing to IL-31-mediated itch in the latter. In cutaneous T-cell lymphoma, the degree of eosinophil infiltration in the skin correlates with how severe the itching is.2PubMed Central. Eosinophils in skin diseases
Research in animal models has added further detail. Eosinophils interact directly with sensory nerves in the skin, increasing levels of substance P in nerve fibers, which in turn amplifies itching responses. These eosinophil-nerve interactions provide a mechanistic link between the immune cells sitting in your skin and the unrelenting urge to scratch.3PubMed Central. Eosinophil-dependent skin innervation and itching following contact toxicant exposure in mice
Allergic and Atopic Causes
Atopic dermatitis is the most common skin disease in which eosinophils play a central role. It is driven by a combination of immune dysregulation and a weakened skin barrier, and eosinophils act as key damage-causing cells. Type 2 immune signals, particularly IL-4, IL-5, and IL-13, recruit eosinophils into affected skin, where they degranulate and release their cytotoxic granule proteins. These proteins directly kill skin cells called keratinocytes, worsen tissue remodeling, and sustain the local inflammatory cycle.4PubMed Central. The Role of and Therapeutic Strategies for Eosinophils in Atopic Dermatitis
Eosinophil numbers in the blood and the levels of granule proteins in circulation tend to be elevated in most people with atopic dermatitis and appear to track with disease severity. Granule proteins are also deposited in skin lesions themselves, reinforcing the idea that eosinophils are not just bystanders but active participants in the disease.5PubMed. Eosinophils and atopic dermatitis
Allergic contact dermatitis can also feature eosinophils, though less consistently. In the diagnostic workup, pathologists consider eosinophils in skin biopsies of atopic or allergic contact dermatitis to be variable: sometimes present, sometimes not, and not required for a definitive diagnosis.6PubMed. The role of eosinophils in the differential diagnosis of inflammatory skin diseases
Drug Reactions With Eosinophilia
DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) is one of the most dangerous eosinophil-associated skin conditions. It typically appears two to eight weeks after starting a new medication, which is a much longer lag than most drug rashes.7PubMed Central. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome
The skin involvement usually begins as an itchy rash resembling measles that rapidly spreads and becomes thickened. It often starts on the face and upper trunk before moving to the arms and legs. A rash is considered suggestive of DRESS when it covers more than half the body surface area. About half of patients develop facial swelling concentrated around the eyes and midface, which can be mistaken for angioedema. Mucous membrane involvement occurs in up to half of patients as well, presenting as lip inflammation or a red, swollen throat. In roughly a fifth to a third of cases, the rash progresses to erythroderma, where virtually the entire body surface is red and scaling. These skin manifestations can persist for weeks to months even after the offending drug is stopped.8World Allergy Organization Journal. DRESS syndrome: A literature review and treatment algorithm
What makes DRESS especially dangerous is that it is not just a skin problem. Marked eosinophilia in the blood is accompanied by organ damage affecting the liver, kidneys, or both. One case report of allopurinol-induced DRESS documented eosinophils reaching 30% of white blood cells, alongside acute kidney injury and liver dysfunction.9PubMed Central. Allopurinol-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report and Review of the Published Evidence From India
Parasitic Infections
Eosinophilia is a hallmark of the body’s response to parasitic worms. Eosinophils evolved in part as anti-parasite defenders: they can kill larval stages of worms in the presence of antibodies or complement proteins, and this host defense function is considered one of their original evolutionary purposes.10PubMed Central. Eosinophils in Helminth Infection: Defenders and Dupes
Several parasitic infections produce distinctive skin symptoms alongside blood eosinophilia. Cutaneous larva migrans, caused by dog or cat hookworm larvae penetrating the skin, produces highly itchy, winding, raised tracks days to weeks after skin contact with contaminated soil or sand. These lesions can last weeks to months without treatment, though blood eosinophilia is only seen in a small minority of cases. Onchocerciasis (river blindness), transmitted by black fly bites in Africa, commonly causes itching, a papular rash, and extremity swelling. In travelers, about 80% show marked eosinophilia with counts reaching 1,000 to 2,000 cells per microliter, although the parasites themselves are hard to find in skin samples from travelers because their exposure is relatively brief.11PubMed Central. Eosinophilia in Infectious Diseases
Hypereosinophilic Syndrome
Hypereosinophilic syndrome (HES) is a rare group of disorders in which persistently elevated eosinophil counts cause damage to one or more organs. Estimates put its prevalence at roughly 0.36 to 6.3 per 100,000 people, and it typically affects adults between ages 20 and 50. HES is divided into neoplastic forms (where the eosinophilia stems from an underlying blood cell cancer), reactive forms (where another disease drives eosinophil production), and idiopathic forms with no identifiable cause.12JAAD Case Reports. The dermatologic and histologic spectrum of hypereosinophilic syndrome
Skin is one of the most commonly affected organs in HES. Different studies report dermatologic involvement in anywhere from about 30% to nearly 70% of patients, with the wide range likely reflecting different patient populations and how involvement was tracked. A recent single-center cohort found skin involvement in roughly 30% of patients, with lungs (39%) and the gastrointestinal tract (31%) somewhat more commonly affected.13PubMed Central. Beyond eosinophil counts: organ involvement patterns across hypereosinophilic syndrome subtypes in a single-center cohort The skin manifestations of HES are varied and can include eczema-like rashes, widespread redness and scaling (erythroderma), hives, thickened skin, and mucosal ulcers. In a minority of cases, skin involvement is the only sign of HES, making it an important diagnosis to keep in mind when skin symptoms are accompanied by persistently high eosinophil counts with no other obvious explanation.14PubMed Central. Hypereosinophilic syndrome: cutaneous involvement as the sole manifestation
One concern with HES is its potential to evolve. The lymphocytic variant of HES can precede or overlap with T-cell lymphoma, suggesting that in some patients, the abnormal immune cell population driving eosinophilia may progress toward overt malignancy over time.15PubMed Central. Lymphocytic Variant Hypereosinophilic Syndrome Overlaps with Angioimmunoblastic T-Cell Lymphoma: A Case Report and Literature Review
Autoimmune Blistering and Bullous Pemphigoid
Bullous pemphigoid (BP) is an autoimmune blistering disease most common in older adults, and eosinophils appear to play a central role in forming the blisters themselves. In BP, the immune system produces antibodies that target proteins at the junction between the outer skin layer and the layer beneath it. Eosinophils line up along this junction, and when activated by IL-5 and BP autoantibodies, they cause the two layers to separate, forming tense, fluid-filled blisters.16PubMed Central. The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease
Experiments using human skin samples showed that blocking eosinophil degranulation almost entirely prevented this skin layer separation. Blocking reactive oxygen species production and eosinophil extracellular trap formation also significantly reduced damage.17PubMed. Evidence for a role of eosinophils in blister formation in bullous pemphigoid These findings position eosinophils not as secondary players in BP but as the cells doing the actual structural damage to the skin.
Rarer Eosinophilic Skin Diseases
Several uncommon dermatoses are defined by eosinophilic infiltration and have distinctive presentations worth recognizing.
Wells syndrome (eosinophilic cellulitis) is a rare condition that can mimic bacterial cellulitis or other skin infections. A reported case involved a patient with three distinct lesions: a blister, a red plaque, and a linear streak on different parts of the body. On biopsy, the hallmark finding was “flame figures,” which are clumps of eosinophils surrounding collagen fibers in the dermis, surrounded by other inflammatory cells.18PubMed. Luna stain: a simple and cost-effective diagnostic tool helps in detecting eosinophilic granules deposition of flame figures and aids in diagnosing eosinophilic cellulitis “Wells Syndrome”
Eosinophilic pustular folliculitis (EPF), also called Ofuji disease, presents with sterile pustules centered on hair follicles. It comes in three forms: the classic type, a form associated with immune suppression (including HIV), and an infantile form. The disease tends to recur and become chronic. One series of ten patients found that initial lesions were scattered papules that gradually merged into circular red plaques, with seven of ten patients reporting itching. The face and trunk were the most commonly affected sites.19PubMed Central. Clinical and Pathological Analysis of 10 Cases of Eosinophilic Pustular Folliculitis An interesting feature of classic EPF is its rapid response to indomethacin, a non-steroidal anti-inflammatory drug. Research suggests this works because eosinophils around hair follicles produce prostaglandin D2, which triggers further eosinophil recruitment via the chemical signal eotaxin-3. Indomethacin interrupts that cycle.2PubMed Central. Eosinophils in skin diseases
Vasculitis and Deep Tissue Involvement
Eosinophilic granulomatosis with polyangiitis (formerly called Churg-Strauss syndrome) is a systemic vasculitis that frequently shows up on the skin. The most common cutaneous findings are purpura and petechiae (small bleeding spots) on the lower legs, along with nodules and papules on the elbows. Biopsies typically show necrotizing granulomas and small-vessel inflammation.20Journal of the American Academy of Dermatology. Cutaneous manifestations of Churg-Strauss syndrome: A clinicopathologic correlation
Eosinophilic fasciitis (Shulman disease) affects deeper tissues rather than the skin surface itself, but its effects are visible and palpable. It causes symmetrical, painful swelling followed by progressive hardening and thickening of the skin and underlying soft tissues, usually in the arms and legs. The diagnosis is confirmed when a deep biopsy shows a thickened fascia infiltrated by lymphocytes and eosinophils.21PubMed. Eosinophilic fasciitis (Shulman disease) MRI can reveal increased signal in the fascia throughout the body, sometimes involving all limbs. One case showed active fasciitis in all muscle groups, predominantly in the legs, without any joint or muscle involvement, illustrating how fasciitis can masquerade as other conditions.22PubMed Central. Eosinophilic fasciitis (Shulman syndrome), a rare entity and diagnostic challenge, as a manifestation of severe chronic graft-versus-host disease: a case report
How Eosinophils Help (and Complicate) Diagnosis
When a pathologist looks at a skin biopsy, the presence or absence of eosinophils can steer the diagnosis in important ways. The diagnostic utility breaks down into a few practical categories. In some conditions, eosinophils are so characteristic that a pathologist would question the diagnosis if they were missing. These include arthropod bite reactions, scabies, urticarial dermatitis, and the dedicated eosinophilic dermatoses. In others, eosinophils are typically rare or absent, and finding them in the biopsy raises a red flag. Graft-versus-host disease and connective tissue disorders fall into this group. For drug reactions and atopic dermatitis, eosinophils are variable and not required for diagnosis. And in conditions like psoriasis and lichen planus, eosinophils are not expected but occasionally show up in small numbers.6PubMed. The role of eosinophils in the differential diagnosis of inflammatory skin diseases
One particularly useful application involves distinguishing graft-versus-host disease from drug eruptions in transplant patients, a notoriously difficult clinical problem. Biopsies of graft-versus-host disease typically show very few eosinophils, and research has found that the presence of even a single eosinophil within a set number of microscopic fields correlates with a non-GVHD diagnosis. More specifically, one study determined that graft-versus-host disease could essentially be excluded when greater than 16 eosinophils per 10 high-power fields were counted.23Human Pathology. The role of eosinophils in the differential diagnosis of inflammatory skin diseases This does not resolve the ambiguity completely, but it gives pathologists a practical threshold to lean on when the clinical picture is murky.
Treatment Approaches Across Eosinophilic Skin Conditions
Treatment depends heavily on the underlying cause. For allergic conditions like atopic dermatitis, the newer biologic drugs that block type 2 immune signals (targeting IL-4, IL-5, or IL-13) have changed the landscape. In conditions driven more directly by eosinophil overproduction, anti-IL-5 agents like mepolizumab and benralizumab have shown promise. A systematic review of their use in Kimura disease, a rare eosinophilic disorder that produces skin and soft tissue masses, found that mepolizumab produced a response in seven of nine cases, while benralizumab showed benefit in all treated patients. These drugs also allowed patients to taper or stop corticosteroids in most cases.24PubMed Central. Therapeutic Efficacy of Anti-Interleukin-5 Monoclonal Antibodies in Kimura Disease: A Systematic Review
Eosinophilic fasciitis is classically steroid-responsive, with methotrexate or mycophenolate used as steroid-sparing alternatives. Biologics or intravenous immunoglobulin are reserved for cases that do not respond.25PubMed Central. A Curious Case of Leg Swelling With Eosinophilic Fasciitis, IgA-κ Monoclonal Gammopathy, Proteinuria, and Bilateral Carpal Tunnel Neuropathy: Diagnostic Convergence of Sclerosing Dermato-Fasciitis and Monoclonal Gammopathy For DRESS syndrome, the priority is identifying and stopping the offending drug, followed by systemic corticosteroids for severe cases. The challenge with DRESS is that skin and organ symptoms can persist long after the drug is discontinued, requiring extended monitoring.
For the classic form of eosinophilic pustular folliculitis, the response to indomethacin is considered so reliable it is virtually diagnostic. This is unusual in dermatology, where most conditions have unpredictable responses to any single drug, and it reflects the specific prostaglandin-driven mechanism at work in the hair follicle.
When Eosinophils in the Skin Point to Something Systemic
Not every eosinophilic skin problem is just a skin problem. A few patterns should raise concern about broader systemic disease. Persistently elevated blood eosinophil counts alongside skin symptoms that do not respond to typical treatments warrant investigation for HES, particularly if there are hints of lung, gut, or cardiac involvement. DRESS syndrome, as discussed above, routinely affects the liver and kidneys alongside the skin. And eosinophilic granulomatosis with polyangiitis frequently involves multiple organ systems, with cardiac involvement being a major source of serious complications.
The lymphocytic variant of HES adds a longer-term concern: the abnormal T-cell clone driving eosinophil production may progress toward T-cell lymphoma, making ongoing surveillance important even after eosinophil counts are controlled. For eosinophilic fasciitis, the association with monoclonal gammopathies and occasional reports of co-occurring blood cancers mean that a basic blood workup should accompany the skin-focused evaluation. These connections underscore that skin-localized eosinophilia sometimes serves as a visible signal of disease happening deeper in the body, and the skin findings can be the earliest or most accessible clue.